|ANIP -- USA Stock|| |
USD 70.49 0.07 0.1%
Mr. Arthur S. Przybyl is President, Chief Executive Officer, Director of the Company
Age: 59 CEO Since 2013
Przybyl is an experienced healthcare executive in a career that spans over 25 years and includes the management of both specialty pharmaceutical and medical device companies. From August 2002 through January 2009, Mr. Przybyl served as President and Chief Executive Officer of Akorn, Inc., a NASDAQlisted specialty pharmaceutical company that manufactures and markets ophthalmic, liquid and lyophilized injectable, and vaccine drug products. Prior to Akorn, Mr. Przybyl was President of privatelyheld company Hearing Innovations, Inc. and President and Chief Operating Officer of NASDAQlisted company Bioject, Inc., both of which are medical device companies. During his career, Mr. Przybyl has held several sales and marketing management positions, including Senior Vice President, Sales and Marketing for International Medication Systems, Inc. and Director, Corporationrationrationrate Marketing and National Accounts for LyphoMed, Inc., both specialty pharmaceutical companies.